BioSpace News Archive

- Data supports pharmacokinetic and safety profile for Neurelis’ lead product, VALTOCO® (diazepam nasal spray), the first and only nasal spray treatment for seizure cluster rescue in pediatric patients 6 years of age and older, adolescents, and adults - Data also further highlights the permeation enhancer potency of Intravail® for both small and large molecules; Intravail is a key component of VALTOCO formulation [20-May-2020]

Airway Therapeutics, Inc., a biopharmaceutical company developing a new class of biologics to break the cycle of injury and inflammation for patients with respiratory and inflammatory diseases, and Celonic Group, a premium biopharmaceutical CDMO s

Precision NanoSystems to Prese CanSinoBIO will license in Precision NanoSystems’ proprietary RNA vaccine platform technology Precision NanoSystems will lead RNA vaccine formulation development CanSinoBIO will lead COVID-19 antigen design, pre-clinical testing and clinical trials TIANJIN, China and VANCOUVER , May 20, 2020 /PRNewswire/ - CanSino Biologics Inc. (Ca

Konica Minolta Precision Medicine , Inc. (KMPM), a subsidiary of Konica Minolta, Inc. (Konica Minolta) today announced the acquisition of the assets of Backpack Health (BPH), a secure mobile and web-based health data management platform. The BPH tool empowers patients to securely store and manage their personal health information and automatically share with caregivers, as well as contribute authorized ano

Contract research organization recognized as a top outsourcing partner for seventh consecutive year by Life Science Leader and Industry Standard Research MORRISVILLE, N.C.--( BUSINESS WIRE )-- Worldwide Clinical Trials, Inc. , (Worldwide) a full-service, midsize, global contract research organization (CRO), today announced that it was honored with five 2020 CRO Leadership Awards, presented by Life Science Leader and Industry Standard Research

Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) is to commence accelerating development of a polygenic risk score (PRS) test to predict an individual’s risk of developing life-threatening complications should they become infected with COVID-19. Dr George Muchnicki CEO said " GENE has secured a data set of over 1,500 patients who experienced COVID-19 and we intend on leveraging our core expertise in predictive risk modelling, to a

New addition to Baxter’s Evo IQ Infusion Platform complements on-market large volumetric pump, offering opportunity to further help personalize treatment Incorporates web-based Dose IQ Safety Software and wireless IQ Enterprise Connectivity Suite to maximize drug library management and advance patient safety Designed to optimize efficiency for clinicians, with the flexibility to help meet future needs DEERFIELD, Ill.--( BUSINE

Fighting the new global pandemic is a top priority in medical research and pharmaceutical development. Hundreds of organizations are working on innovations to reduce the impact of the disease and prevent further infection. An article from Johns Hopkins pointed o

The ongoing COVID-19 pandemic is having a significant impact on medical students. As universities have shifted to virtual learning models and online classes, students have had to shift their learning and study habits.

As Founder & Chief Visionary Officer, Dr. Susan Love, MD, MBA advanced through her career as a breast surgeon she became increasingly frustrated by the fact that the research being performed on the breast and breast cancer was being done on mice and rats